Amgen Positioned to Deliver Attractive Growth Over Next Five Years domain-B, India - Amgen is anticipating 17 key Phase 2 and 3 clinical study results in 2009 and 2010, including for denosumab (oncology), AMG 386 and AMG 655 for various ... |
« Mesothelioma Clinical Trials - Best Syndication | Main | Are doctors soon set to grasp the biggest prize in cancer research? - Irish Independent »
November 18, 2008
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883301053602b015970c
Listed below are links to weblogs that reference Amgen Positioned to Deliver Attractive Growth Over Next Five Years - domain-B:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Last articles
- Les nouveaux moteurs de la semaine : Rue des Professionnels, ReportLinker, Volti, Annuaire Entreprises, Jetcost et Wasalive (Abondance actu - vendredi 9 mars 2007)
- Reportlinker.com : un moteur de recherche d'études de marché.... - Le JP Blog - technoselect
- Reportlinker, lauréat de Tremplin Entreprises, 8 et 9 juilllet 2008, au Sénat, le premier événement du capital investissement en France
- Un moteur de recherche dédié aux études de marchés: Reportlinker
- Reportlinker, le moteur de recherche d'études de marché
- Sparus, Reportlinker et Quescom espoirs 2007 de l'IE-Club
- Reportlinker: L'IE-Club récompense les PME françaises innovantes
- Le prix IE-Club distingue les PME Kxen, Sparus Software et Reportlinker
- Présentation vidéo de Reportlinker
- Jeudi 2.0 : Recherche verticale ou méta recherche - Reportlinker
Comments